HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetes.
作者信息
Papastergiou John, Rajan Amy, Diamantouros Artemis, Zervas John, Chow Justin, Tolios Peter
出版信息
Can Pharm J (Ott). 2012 Jul;145(4):165-7. doi: 10.3821/145.4.cpj165.
Abstract
摘要
相似文献
1
HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetes.社区药房中的糖化血红蛋白（HbA1c）检测：改善糖尿病患者护理的新策略。
Can Pharm J (Ott). 2012 Jul;145(4):165-7. doi: 10.3821/145.4.cpj165.
2
Development and implementation of a collaboration between a patient-centered medical home and community pharmacy.以患者为中心的医疗之家与社区药房之间的合作的发展与实施。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):122-129. doi: 10.1016/j.japh.2019.09.022. Epub 2019 Dec 20.
3
Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.基于电话干预对2型糖尿病患者的疗效：药学实践中的一项随机对照试验
Int J Clin Pharm. 2018 Apr;40(2):345-353. doi: 10.1007/s11096-018-0593-0. Epub 2018 Feb 12.
4
A Systematic Review on Pharmaceutical Diabetic Care Services in the United Arab Emirates (UAE).阿联酋的药学糖尿病护理服务的系统评价。
Curr Diabetes Rev. 2021;17(6):e122820189559. doi: 10.2174/1573399817999201228210029.
5
Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes.利用临床药学专家解决退伍军人糖尿病管理中获得医疗服务的障碍问题。
J Pharm Pract. 2017 Aug;30(4):412-418. doi: 10.1177/0897190016663952. Epub 2016 Aug 27.
6
A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients.糖尿病患者的新型病例管理员：社区药剂师及药学服务在糖尿病患者病例管理中作用的试点观察性研究
Pharmacy (Basel). 2020 Oct 19;8(4):193. doi: 10.3390/pharmacy8040193.
7
Effects of Point-Of-Care Testing in General Practice for Type 2 Diabetes Patients on Ambulatory Visits and Hospitalizations.基层医疗机构即时检测对 2 型糖尿病患者门诊就诊和住院的影响。
Int J Environ Res Public Health. 2020 Aug 26;17(17):6185. doi: 10.3390/ijerph17176185.
8
The detection of influenza virus at the community pharmacy to improve the management of local residents with influenza or influenza-like disease.在社区药房检测流感病毒，以改善对当地流感或流感样疾病患者的管理。
J Pharm Health Care Sci. 2017 Aug 8;3:22. doi: 10.1186/s40780-017-0091-x. eCollection 2017.
9
Making pharmacogenetic testing a reality in a community pharmacy.在社区药房实现药物遗传学检测。
J Am Pharm Assoc (2003). 2012;52(6):e259-65. doi: 10.1331/JAPhA.2012.12108.
10
Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.基于社区药房的干预措施改善高血压患者用药依从性的评价：一项随机对照试验。
BMC Health Serv Res. 2010 Feb 5;10:34. doi: 10.1186/1472-6963-10-34.
引用本文的文献
1
Clinical Need for Point-of-Care Testing for Diabetes in Clinical and Laboratory Improvement Amendments-Waived Settings.临床与实验室改进修正案豁免环境下糖尿病即时检测的临床需求
Clin Diabetes. 2024 Oct 30;43(2):227-239. doi: 10.2337/cd24-0071. eCollection 2025 Spring.
2
Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program.将快速糖尿病筛查纳入以拉丁裔为重点的基于社区的低障碍COVID-19检测项目。
JAMA Netw Open. 2022 May 2;5(5):e2214163. doi: 10.1001/jamanetworkopen.2022.14163.
3
Beliefs About Medicine and Glycemic Control Among Type 2 Diabetes Patients: A Cross-Sectional Study in West Bank, Palestine.《巴勒斯坦西岸 2 型糖尿病患者对药物的信念与血糖控制情况的横断面研究》
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720971919. doi: 10.1177/2150132720971919.
4
Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.基于社区药房的估算肾小球滤过率（eGFR）筛查，用于高危患者慢性肾脏病（CKD）的早期检测。
Can J Kidney Health Dis. 2020 May 18;7:2054358120922617. doi: 10.1177/2054358120922617. eCollection 2020.
5
Community pharmacy-based screening for patients with uninvestigated dyspepsia.基于社区药房对未经调查的消化不良患者进行筛查。
Can Pharm J (Ott). 2020 Feb 18;153(2):101-107. doi: 10.1177/1715163520903065. eCollection 2020 Mar-Apr.
6
Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.挪威药房糖化血红蛋白（HbA1c）检测的质量控制：一个适度的开端。
J Diabetes Sci Technol. 2018 Jul;12(4):753-761. doi: 10.1177/1932296818766378. Epub 2018 Apr 5.
7
Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.挪威社区药房中用于识别未确诊2型糖尿病患者的风险评估和糖化血红蛋白测量——一项可行性研究
PLoS One. 2018 Feb 23;13(2):e0191316. doi: 10.1371/journal.pone.0191316. eCollection 2018.
8
Point-of-Care HbA1c Testing with the A1cNow Test Kit in General Practice Dental Clinics: A Pilot Study Involving Its Accuracy and Practical Issues in Its Use.在全科牙科诊所使用A1cNow检测试剂盒进行即时糖化血红蛋白（HbA1c）检测：一项关于其准确性及使用中实际问题的初步研究
Point Care. 2014 Dec;13(4):142-147. doi: 10.1097/POC.0000000000000039.
9
Diabetic Profile- Screening of HBA1C - A Random Community Assessment.糖尿病概况 - 糖化血红蛋白（HbA1c）筛查 - 一项随机社区评估
J Clin Diagn Res. 2013 Oct;7(10):2200-2. doi: 10.7860/JCDR/2013/5690.3470. Epub 2013 Oct 5.
本文引用的文献
1
Glycemic control in community-dwelling patients with type 2 diabetes.社区居住的2型糖尿病患者的血糖控制
Can Pharm J (Ott). 2012 Mar;145(2):68-69.e1. doi: 10.3821/145.2.cpj68.
2
Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern?糖化血红蛋白检测的认证方法中的分析偏差：值得关注的一个原因？
Am J Clin Pathol. 2008 Apr;129(4):540-7. doi: 10.1309/U3GPPTCBP1VLL8AW.
3
Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study).加拿大初级医疗环境中的血糖控制与发病率（加拿大糖尿病评估研究结果）
Diabetes Res Clin Pract. 2005 Oct;70(1):90-7. doi: 10.1016/j.diabres.2005.03.024.
4
Standards of medical care in diabetes.糖尿病医疗护理标准
Diabetes Care. 2005 Jan;28 Suppl 1:S4-S36.
5
A diabetes report card for the United States: quality of care in the 1990s.美国糖尿病报告卡：20世纪90年代的护理质量
Ann Intern Med. 2002 Apr 16;136(8):565-74. doi: 10.7326/0003-4819-136-8-200204160-00005.
6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
Zotero 插件